Hebang Biology
Latest round
- Series E
Last raised
- Jan 2015
Total raised
- $27M
Investors
- 5
About Hebang Biology
Established in 2006 and based in Wuxi, China, Hebang Biology operates as a biotech pharmaceutical company dedicated to the research and development of genetically engineered protein drugs. The company mainly provides genetically engineered protein drugs. Products are used to treat diabetes, tumors, congestive heart failure, viral chronic hepatitis B, hepatitis C, etc. The company generates revenue by providing genetically engineered protein drugs.
Who invested in Hebang Biology
5 investors across 4 rounds
See all investors in Hebang Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hebang Biology
Who invested in Hebang Biology?
Hebang Biology has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hebang Biology raised?
Hebang Biology has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Hebang Biology last raise money?
Hebang Biology's most recent round on record is a Series E, in Jan 2015.
What does Hebang Biology do?
Established in 2006 and based in Wuxi, China, Hebang Biology operates as a biotech pharmaceutical company dedicated to the research and development of genetically engineered protein drugs.
Where is Hebang Biology headquartered?
Hebang Biology is headquartered in Wuxi, China.
Which VCs invest in companies like Hebang Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Hebang Biology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Hebang Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.